We are live on
!
Find out more
ETM
Euclidean Technologies Management Portfolio holdings
AUM
$109M
1-Year Est. Return
7.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.43%
1 Year Est. Return
+7.18%
3 Year Est. Return
+123.73%
5 Year Est. Return
+76.06%
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$10.5M
(+9.2%)
Cap. Flow
+$7.47M
Cap. Flow
% of AUM
5.96%
Top 10 Holdings %
Top 10 Hldgs %
23.54%
Holding
104
New
35
Increased
23
Reduced
10
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MarineMax
HZO
|
+$2.71M |
| 2 |
Perdoceo Education
PRDO
|
+$2.58M |
| 3 |
Star Group
SGU
|
+$2.4M |
| 4 |
American Public Education
APEI
|
+$2.33M |
| 5 |
Ingles Markets
IMKTA
|
+$2.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medifast
MED
|
+$3.6M |
| 2 |
Super Micro Computer
SMCI
|
+$2.93M |
| 3 |
Oshkosh
OSK
|
+$2.65M |
| 4 |
Meritage Homes
MTH
|
+$1.93M |
| 5 |
Anika Therapeutics
ANIK
|
+$1.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 38.86% |
| 2 | Consumer Discretionary | 19.96% |
| 3 | Consumer Staples | 13.12% |
| 4 | Technology | 10.18% |
| 5 | Healthcare | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Photronics
PLAB
$1.7B
| $1.31M | 1.04% |
98,874
| – | – |
|
52
ePlus
PLUS
$2.33B
| $1.19M | 0.95% |
27,536
| – | – |
|
53
Lear
LEA
$7.1B
| $1.18M | 0.94% |
6,744
| – | – |
|
54
Sanmina
SANM
$10.6B
| $1.18M | 0.94% |
30,338
-30,000
| -50% | -$1.24M |
|
55
IDT Corp
IDT
$1.57B
| $370K | 0.29% |
+10,008
| New | +$284K |
|
56
Atkore
ATKR
$2.48B
| $359K | 0.29% |
5,050
+1,250
| +33% | +$95.2K |
|
|
QVCGA
57
DELISTED
QVC Group Inc Series A
QVCGA
| $306K | 0.24% |
468
+72
| +18% | +$46.2K |
|
58
MasTec
MTZ
$26B
| $302K | 0.24% |
2,850
| – | – |
|
59
Ziff Davis
ZD
$1.99B
| $286K | 0.23% |
2,394
+438
| +22% | +$48.1K |
|
60
Biogen
BIIB
$30.4B
| $256K | 0.2% |
+739
| New | +$224K |
|
|
PARA
61
DELISTED
Paramount Global Class B
PARA
| $248K | 0.2% |
+5,496
| New | +$227K |
|
62
QuidelOrtho
QDEL
$1.19B
| $248K | 0.2% |
+1,932
| New | +$227K |
|
63
Ironwood Pharmaceuticals
IRWD
$635M
| $238K | 0.19% |
+18,475
| New | +$211K |
|
64
Emergent Biosolutions
EBS
$394M
| $236K | 0.19% |
+3,741
| New | +$240K |
|
|
ODP
65
DELISTED
ODP
ODP
| $235K | 0.19% |
4,886
| – | – |
|
|
ALXN
66
DELISTED
Alexion Pharmaceuticals
ALXN
| $235K | 0.19% |
+1,277
| New | +$219K |
|
67
Labcorp
LH
$23.2B
| $234K | 0.19% |
+988
| New | +$225K |
|
68
Sturm, Ruger & Co
RGR
$603M
| $234K | 0.19% |
+2,601
| New | +$195K |
|
69
AbbVie
ABBV
$450B
| $233K | 0.19% |
+2,071
| New | +$233K |
|
70
Sterling Infrastructure
STRL
$19.6B
| $233K | 0.19% |
+9,650
| New | +$216K |
|
71
Emcor
EME
$33.1B
| $230K | 0.18% |
1,870
| – | – |
|
72
HP
HPQ
$22.7B
| $230K | 0.18% |
+7,608
| New | +$243K |
|
73
Revvity
RVTY
$12.3B
| $228K | 0.18% |
+1,475
| New | +$207K |
|
74
DXC Technology
DXC
$1.53B
| $226K | 0.18% |
+5,801
| New | +$207K |
|
|
EFOR
75
Everforth Inc
EFOR
$768M
| $225K | 0.18% |
2,319
| – | – |
|
Similar funds
CWM
ACM
RA
AMC
BCM
HLCM
TWP
PCM
Euclidean Technologies Management's Q2 2021 Portfolio in Review
As of Q2 2021, Euclidean Technologies Management held 104 positions worth $125M, up 9.2% from $115M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Euclidean Technologies Management deployed $7.47M of net new capital in Q2 2021, opening 35 new positions and adding to 23 existing holdings. Its largest new stake was Perdoceo Education: 211,239 shares worth $2.59M.
By sector, the portfolio is most concentrated in Industrials at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Shoe Station Group, an estimated $1.42M trimmed.
- Euclidean Technologies Management's largest Q2 2021 buy was Perdoceo Education: 211,239 shares worth $2.59M.
- Euclidean Technologies Management added most to MarineMax in Q2 2021, an estimated $2.71M increase.
- Euclidean Technologies Management's biggest Q2 2021 reduction was Shoe Station Group, cutting an estimated $1.42M.
- Euclidean Technologies Management fully exited Medifast in Q2 2021, selling an estimated $3.6M.
- Euclidean Technologies Management's ten largest holdings make up 24% of its $125M portfolio in Q2 2021.
- Euclidean Technologies Management opened 35 new positions and closed 9 in Q2 2021.
- Euclidean Technologies Management's portfolio value rose 9.2% quarter-over-quarter to $125M.
Based on Euclidean Technologies Management's 13F filing for Q2 2021, filed 5 Aug 2021.